People Background Check
Find People:

Michael W Kavanaugh, Age 93319 12Th St, Petaluma, CA 94952

Get Report
Known as:
Mike W Kavanaugh Michael W Kavnaugh Michael Tedesco Joseph Richards Randall Dopp Joseph Richards-Thomas
Related to:
Kristopher Michael Kavanaugh 44

Michael Kavanaugh Phones & Addresses

Petaluma, CA

Valley Center, CA

Oceanside, CA

Julian, CA

840 Boardman Rd, Aiken, SC 29803 (803) 642-7143

Indian Springs, NV

Oak Ridge, TN

New Ellenton, SC

San Marcos, CA

Show more

Work

Company: Dentons US LLP Address:

Mentions for Michael W Kavanaugh

Career records & work history

Lawyers & Attorneys

Michael Kavanaugh Photo 1

Michael Kavanaugh - Lawyer

Office:
Dentons US LLP
Specialties:
Government Contracts Law, Technology Law, Litigation
ISLN:
905993018
Admitted:
1971
University:
Marquette University, B.B.A., 1969
Law School:
Marquette University Law School, J.D., 1971

Medicine Doctors

Michael Kavanaugh Photo 2

Michael Joseph Kavanaugh

Specialties:
General Practice
Education:
Loyola University Chicago (2005) Surgery

Michael Kavanaugh resumes & CV records

Resumes

Michael Kavanaugh Photo 48

Michael J Kavanaugh

Michael Kavanaugh Photo 49

Michael Kavanaugh

Michael Kavanaugh Photo 50

Michael Kavanaugh

Michael Kavanaugh Photo 51

Michael Kavanaugh

Skills:
Microsoft Word, Microsoft Office
Michael Kavanaugh Photo 52

Michael Kavanaugh

Michael Kavanaugh Photo 53

Michael F Kavanaugh

Michael Kavanaugh Photo 54

Michael Kavanaugh

Michael Kavanaugh Photo 55

Michael Kavanaugh

Location:
United States

Publications & IP owners

Us Patents

Human Fgf-21 Nucleic Acids

US Patent:
6716626, Apr 6, 2004
Filed:
Nov 16, 2000
Appl. No.:
09/715805
Inventors:
Nobuyuki Itoh - Kyoto, JP
Michael Kavanaugh - Mill Valley CA
Assignee:
Chiron Corporation - Emeryville CA
Kyoto University - Kyoto
International Classification:
C12N 1585
US Classification:
435325, 4352523, 43525411, 4352542, 4353201, 435 691, 536 231, 536 235, 536 243, 530350
Abstract:
This invention relates to human fibroblast growth factor (hFGF-21), and to variants thereof and to polynucleotides encoding FGF-21. The invention also relates to diagnostic and therapeutic agents related to the polynucleotides and proteins, including probes and antibodies, and to methods of treating liver disease such as cirrhosis and cancer, methods of treating conditions related to thymic function, and methods of treating conditions of the testis. The invention also relates to mouse fibroblast growth factor (mFGF-21), and to variants thereof and polynucleotides encoding mFGF-21.

Human Fgf-20 Gene And Gene Expression Products

US Patent:
6797695, Sep 28, 2004
Filed:
Oct 20, 2000
Appl. No.:
09/692945
Inventors:
Nobuyuki Itoh - Kyoto, JP
Michael Kavanaugh - Mill Valley CA
Assignee:
Kyoto University - Kyoto
Chiron Corporation - Emeryville CA
International Classification:
A61K 3818
US Classification:
514 12, 530350
Abstract:
This invention relates to human fibroblast growth factor (hFGF-20), and to variants thereof and to polynucleotides encoding FGF-20. The invention also relates to diagnostic and therapeutic agents related to the polynucleotides and proteins, including probes and antibodies, to methods of treating neuronal degenerative disease such as Parkinsons disease and to methods of treating disorders of the cochlea including those causing hearing loss. The invention also relates to rat fibroblast growth factor (rFGF-20), and to variants thereof and polynucleotides encoding rFGF-20.

Human Fgf-21 Gene And Gene Expression Products

US Patent:
7723297, May 25, 2010
Filed:
Apr 17, 2006
Appl. No.:
11/405241
Inventors:
Nobuyuki Itoh - Sakya, JP
Michael Kavanaugh - Mill Valley CA, US
Assignee:
Kyoto University - Sakyo, Kyoto
Novartis Vaccines and Diagnostics, Inc. - Emeryville CA
International Classification:
A61K 38/18
C07K 14/475
US Classification:
514 12, 530350, 530300
Abstract:
This invention relates to human fibroblast growth factor (hFGF-21), and to variants thereof and to polynucleotides encoding FGF-21. The invention also relates to diagnostic and therapeutic agents related to the polynucleotides and proteins, including probes and antibodies, and to methods of treating liver disease such as cirrhosis and cancer, methods of treating conditions related to thymic function, and methods of treating conditions of the testis. The invention also relates to mouse fibroblast growth factor (mFGF-21), and to variants thereof and polynucleotides encoding mFGF-21.

Human Fgf-21 Gene And Gene Expression Products

US Patent:
2004018, Sep 23, 2004
Filed:
Apr 5, 2004
Appl. No.:
10/818140
Inventors:
Nobuyuki Itoh - Sakyo, JP
Michael Kavanaugh - Mill Valley CA, US
Assignee:
Chiron Corporation - Emeryville CA
International Classification:
C07K014/50
C12Q001/68
C07H021/04
US Classification:
435/006000, 435/069100, 435/320100, 435/325000, 530/399000, 536/023500
Abstract:
This invention relates to human fibroblast growth factor (hFGF-21), and to variants thereof and to polynucleotides encoding FGF-21. The invention also relates to diagnostic and therapeutic agents related to the polynucleotides and proteins, including probes and antibodies, and to methods of treating liver disease such as cirrhosis and cancer, methods of treating conditions related to thymic function, and methods of treating conditions of the testis. The invention also relates to mouse fibroblast growth factor (mFGF-21), and to variants thereof and polynucleotides encoding mFGF-21.

Human Fgf-21 Gene And Gene Expression Products

US Patent:
2005003, Feb 17, 2005
Filed:
Feb 3, 2004
Appl. No.:
10/771173
Inventors:
Nobuyuki Itoh - Sakyo, JP
Michael Kavanaugh - Mill Valley CA, US
Assignee:
Chiron Corporation - Emeryville CA
International Classification:
C07K014/49
US Classification:
435069100, 435320100, 435325000, 530399000, 536023500
Abstract:
This invention relates to human fibroblast growth factor (hFGF-21), and to variants thereof and to polynucleotides encoding FGF-21. The invention also relates to diagnostic and therapeutic agents related to the polynucleotides and proteins, including probes and antibodies, and to methods of treating liver disease such as cirrhosis and cancer, methods of treating conditions related to thymic function, and methods of treating conditions of the testis. The invention also relates to mouse fibroblast growth factor (mFGF-21), and to variants thereof and polynucleotides encoding mFGF-21.

Human Fgf-20 Gene And Gene Expression Products

US Patent:
2006017, Aug 3, 2006
Filed:
Dec 27, 2005
Appl. No.:
11/318327
Inventors:
Nobuyuki Itoh - Kyoto, JP
Michael Kavanaugh - Mill Valley CA, US
Assignee:
Chiron Corporation - Emeryville CA
International Classification:
C07K 14/50
A61K 38/18
C07K 16/22
C12P 21/06
C07H 21/04
US Classification:
435069100, 530350000, 530388240, 435320100, 435325000, 514012000, 536023500
Abstract:
This invention relates to human fibroblast growth factor (hFGF-20), and to variants thereof and to polynucleotides encoding FGF-20. The invention also relates to diagnostic and therapeutic agents related to the polynucleotides and proteins, including probes and antibodies, to methods of treating neuronal degenerative disease such as Parkinson's disease and to methods of treating disorders of the cochlea including those causing hearing loss. The invention also relates to rat fibroblast growth factor (rFGF-20), and to variants thereof and polynucleotides encoding rFGF-20.

Human Fgf-21 Gene And Gene Expression Products

US Patent:
2007012, Jun 7, 2007
Filed:
May 26, 2006
Appl. No.:
11/441666
Inventors:
Nobuyuki Itoh - Kyoto, JP
Michael Kavanaugh - Mill Valley CA, US
Assignee:
Novartis Vaccines and Diagnostics - Emeryville CA
Kyoto University - Kyoto
International Classification:
C12Q 1/68
G01N 33/53
C07H 21/04
C12P 21/06
C07K 14/50
C07K 16/22
US Classification:
435006000, 435007100, 435069100, 435320100, 435325000, 530399000, 536023500, 530388250
Abstract:
This invention relates to human fibroblast growth factor (hFGF-21), and to variants thereof and to polynucleotides encoding FGF-2 1. The invention also relates to diagnostic and therapeutic agents related to the polynucleotides and proteins, including probes and antibodies, and to methods of treating liver disease such as cirrhosis and cancer, methods of treating conditions related to thymic function, and methods of treating conditions of the testis. The invention also relates to mouse fibroblast growth factor (mFGF-21), and to variants thereof and polynucleotides encoding mFGF-21.

Human Fgf-21 Gene And Gene Expression Products

US Patent:
2009007, Mar 19, 2009
Filed:
Aug 16, 2007
Appl. No.:
11/894005
Inventors:
Nobuyuki Itoh - Kyoto, JP
Michael Kavanaugh - Mill Valley CA, US
Assignee:
Novartis Vaccines and Diagnostics - Emeryville CA
Kyoto University - Kyoto
International Classification:
A61K 39/395
C07H 21/04
C12N 15/63
C12N 15/00
C12N 5/00
A61K 35/12
C12Q 1/68
A61K 31/7088
C12P 21/06
C07K 14/435
C07K 16/00
US Classification:
4241391, 536 235, 4353201, 435455, 435325, 435 691, 530350, 5303879, 514 44, 424 9321, 435 6
Abstract:
This invention relates to human fibroblast growth factor (hF-GF-21), and to variants thereof and to polynucleotides encoding FGF-21. The invention also relates to diagnostic and therapeutic agents related to the polynucleotides and proteins, including probes and antibodies, and to methods of treating liver disease such as cirrhosis and cancer, methods of treating conditions related to thymic function, and methods of treating conditions of the testis. The invention also relates to mouse fibroblast growth factor (mFGF-21), and to variants thereof and polynucleotides encoding mFGF-21.

Isbn (Books And Publications)

The Equal Access To Justice Act

Author:
Michael T. Kavanaugh
ISBN #:
0897072979

The Complete Guide To Monkeys, Apes And Other Primates

Author:
Michael Kavanaugh
ISBN #:
0224021680

The Complete Guide To Monkeys, Apes And Other Primates

Author:
Michael Kavanaugh
ISBN #:
0670435430

Possible Relatives

Dennis P Kavanaugh  Elizabeth A Kavanaugh  Erin E Kavanaugh  Forrest M Kavanaugh  Gloria M Kavanaugh  Helen A Kavanaugh  Jack I Kavanaugh  Michael A Last  Michael D Stanaland  Michael Stanberry 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.